DAY ONE BIOPHARMACEUTICALS I

About

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapies for patients of all ages with genetically defined cancers. The company’s pipeline is anchored by its lead product candidate, which aims to address high unmet medical needs in pediatric and adult oncology. By leveraging precision medicine approaches, Day One Biopharmaceuticals seeks to transform the treatment landscape for specific cancer indications.